137 related articles for article (PubMed ID: 22649695)
21. Inclusion of the murine IgGκ signal peptide increases the cellular immunogenicity of a simian adenoviral vectored Plasmodium vivax multistage vaccine.
Fonseca JA; McCaffery JN; Caceres J; Kashentseva E; Singh B; Dmitriev IP; Curiel DT; Moreno A
Vaccine; 2018 May; 36(20):2799-2808. PubMed ID: 29657070
[TBL] [Abstract][Full Text] [Related]
22. In vivo and in vitro gene transfer and expression in rat intestinal epithelial cells by E1-deleted adenoviral vector.
Cheng DY; Kolls JK; Lei D; Noel RA
Hum Gene Ther; 1997 Apr; 8(6):755-64. PubMed ID: 9113515
[TBL] [Abstract][Full Text] [Related]
23. Immune response to full-length dystrophin delivered to Dmd muscle by a high-capacity adenoviral vector.
Gilchrist SC; Ontell MP; Kochanek S; Clemens PR
Mol Ther; 2002 Sep; 6(3):359-68. PubMed ID: 12231172
[TBL] [Abstract][Full Text] [Related]
24. DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle.
Chen HH; Mack LM; Choi SY; Ontell M; Kochanek S; Clemens PR
Hum Gene Ther; 1999 Feb; 10(3):365-73. PubMed ID: 10048389
[TBL] [Abstract][Full Text] [Related]
25. Fas ligand gene-carrying adeno-5 AdEasy viruses can be efficiently propagated in apoptosis-sensitive human embryonic retinoblast 911 cells.
Watzlik A; Dufter C; Jung M; Opelz G; Terness P
Gene Ther; 2000 Jan; 7(1):70-4. PubMed ID: 10680018
[TBL] [Abstract][Full Text] [Related]
26. Single Plasmid-Based, Upgradable, and Backward-Compatible Adenoviral Vector Systems.
Liu H; Lu Z; Zhang X; Guo X; Mei L; Zou X; Zhong Y; Wang M; Hung T
Hum Gene Ther; 2019 Jun; 30(6):777-791. PubMed ID: 30793964
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of mucosal innate and adaptive immunity following intranasal immunization of mice with a bovine adenoviral vector.
Sayedahmed EE; Elshafie NO; Zhang G; Mohammed SI; Sambhara S; Mittal SK
Front Immunol; 2023; 14():1305937. PubMed ID: 38077380
[TBL] [Abstract][Full Text] [Related]
28. Passive immunization with a recombinant adenovirus expressing an HA (H5)-specific single-domain antibody protects mice from lethal influenza infection.
Tutykhina IL; Sedova ES; Gribova IY; Ivanova TI; Vasilev LA; Rutovskaya MV; Lysenko AA; Shmarov MM; Logunov DY; Naroditsky BS; Tillib SV; Gintsburg AL
Antiviral Res; 2013 Mar; 97(3):318-28. PubMed ID: 23274786
[TBL] [Abstract][Full Text] [Related]
29. Construction and immunogenicity of recombinant adenovirus vaccines expressing the HMW1, HMW2, or Hia adhesion protein of nontypeable Haemophilus influenzae.
Winter LE; Barenkamp SJ
Clin Vaccine Immunol; 2010 Oct; 17(10):1567-75. PubMed ID: 20685934
[TBL] [Abstract][Full Text] [Related]
30. Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses.
Ilan Y; Sauter B; Chowdhury NR; Reddy BV; Thummala NR; Droguett G; Davidson A; Ott M; Horwitz MS; Chowdhury JR
Hepatology; 1998 May; 27(5):1368-76. PubMed ID: 9581693
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of rabies virus multiplication by siRNA delivered through adenoviral vector in vitro in BHK-21 cells and in vivo in mice.
Sonwane AA; Dahiya SS; Saini M; Chaturvedi VK; Singh RP; Gupta PK
Res Vet Sci; 2012 Aug; 93(1):498-503. PubMed ID: 21767857
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA silencing improves the tumor specificity of adenoviral transgene expression.
Card PB; Hogg RT; Gil Del Alcazar CR; Gerard RD
Cancer Gene Ther; 2012 Jul; 19(7):451-9. PubMed ID: 22555510
[TBL] [Abstract][Full Text] [Related]
33. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries.
Lee SW; Trapnell BC; Rade JJ; Virmani R; Dichek DA
Circ Res; 1993 Nov; 73(5):797-807. PubMed ID: 8403251
[TBL] [Abstract][Full Text] [Related]
34. Construction of a novel oncolytic adenoviral vector and its biological characteristics.
Zhang M; Zhang X; Han Z; Chen X; Yang L; Sheng Y; Wen J
Oncol Rep; 2013 Feb; 29(2):798-804. PubMed ID: 23165979
[TBL] [Abstract][Full Text] [Related]
35. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
[TBL] [Abstract][Full Text] [Related]
36. Construction of recombinant adenoviral vector Ad-CMV-hTGFbeta1 for reversion of intervertebral disc degeneration by gene transfer.
Tan J; Hu Y; Zheng H; Li S
Chin J Traumatol; 2002 Apr; 5(2):97-102. PubMed ID: 11904071
[TBL] [Abstract][Full Text] [Related]
37. Organ distribution of transgene expression following intranasal mucosal delivery of recombinant replication-defective adenovirus gene transfer vector.
Damjanovic D; Zhang X; Mu J; Fe Medina M; Xing Z
Genet Vaccines Ther; 2008 Feb; 6():5. PubMed ID: 18261231
[TBL] [Abstract][Full Text] [Related]
38. Genetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominis.
Burmistrova DA; Tillib SV; Shcheblyakov DV; Dolzhikova IV; Shcherbinin DN; Zubkova OV; Ivanova TI; Tukhvatulin AI; Shmarov MM; Logunov DY; Naroditsky BS; Gintsburg AL
PLoS One; 2016; 11(3):e0150958. PubMed ID: 26962869
[TBL] [Abstract][Full Text] [Related]
39. Efficient adenoviral vector-directed expression of a foreign gene to neurons and sustentacular cells in the mouse olfactory neuroepithelium.
Holtmaat AJ; Hermens WT; Oestreicher AB; Gispen WH; Kaplitt MG; Verhaagen J
Brain Res Mol Brain Res; 1996 Sep; 41(1-2):148-56. PubMed ID: 8883946
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
